Alterity Therapeutics Ltd. (AU:ATH) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Alterity Therapeutics has appointed Abby Macnish Niven as the new Company Secretary following her recent role as Chief Financial Officer. With a strong background in finance and governance, Ms. Macnish Niven brings extensive expertise to the company as it pursues advancements in treating neurodegenerative diseases. This leadership change signals a strategic move for Alterity as it continues its focus on innovative drug development.
For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.